ACLX vs REGN: Which Stock is Better?

Side-by-side comparison of Arcellx Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

ACLX

Arcellx Inc

$72.17

REGN

Regeneron Pharmaceuticals Inc

$733.78

Key Metrics Comparison

MetricACLXREGNWinner
Market Cap$4.17B$77.77BREGN
P/E RatioN/A17.58REGN
EPS (TTM)$N/A$41.75REGN
Revenue Growth-0.8%0.0%REGN
Gross Margin-368.5%45.8%REGN

Analyze ACLX

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ACLX or REGN a better investment?

Comparing ACLX and REGN: Arcellx Inc has a market cap of $4.17B while Regeneron Pharmaceuticals Inc has $77.77B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ACLX and REGN?

ACLX (Arcellx Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ACLX or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ACLX or REGN?

REGN has higher revenue growth at 0.0% vs -0.8% for ACLX.

Which company is more profitable: ACLX or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 45.8% compared to -368.5% for ACLX.

Which is the larger company: ACLX or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.77B compared to $4.17B for ACLX.

Should I buy ACLX or REGN in 2026?

Both ACLX and REGN have investment merit. ACLX trades at $72.17 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ACLX and REGN stock?

Key differences: Market Cap ($4.17B vs $77.77B), P/E Ratio (N/A vs 17.6x), Revenue Growth (-0.8% vs 0.0%), Gross Margin (-368.5% vs 45.8%).

Popular Stock Comparisons